Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-63
Closed -$6.2K 843
2025
Q2
$6.2K Hold
63
﹤0.01% 628
2025
Q1
$5.84K Buy
+63
New +$5.81K ﹤0.01% 694

Other funds holding AMED

N.E.W. Advisory Services's AMED Position: Q3 2025 in Review

N.E.W. Advisory Services sold out of Amedisys (AMED) in Q3 2025, closing a stake of 63 shares — an estimated $6.2K sold.

N.E.W. Advisory Services first reported a position in AMED in Q1 2025 and held it in 2 quarters. The position peaked at $6.2K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • N.E.W. Advisory Services reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • N.E.W. Advisory Services sold 63 Amedisys shares in Q3 2025, an estimated $6.2K.
  • N.E.W. Advisory Services first reported a position in Amedisys in Q1 2025 and held it in 2 quarters.
  • N.E.W. Advisory Services's Amedisys position peaked at $6.2K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on N.E.W. Advisory Services's 13F filing for Q3 2025, filed 27 Oct 2025.